Cathay Biotech (SHSE:688065) Change In Inventory: ¥0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688065 Cathay Biotech Inc SHSE:688065
93 GF Score
Price ¥39.86
GF Value ¥49.84
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cathay Biotech Change In Inventory?

Cathay Biotech SHSE:688065 +0.66% 93 Change In Inventory is ¥0 Mil as of Jun. 2026. GuruFocus rates SHSE:688065 with a GF Score™ of 93/100 and a GF Value™ of ¥49.84 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Cathay Biotech's change in inventory for the quarter that ended in Jun. 2026 was ¥0 Mil. It means Cathay Biotech's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Cathay Biotech's change in inventory for the fiscal year that ended in Dec. 2025 was ¥-395 Mil. It means Cathay Biotech's inventory increased by ¥395 Mil from Dec. 2024 to Dec. 2025 .

Cathay Biotech's Total Inventories for the quarter that ended in Jun. 2026 was ¥1,407 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cathay Biotech's Days Inventory for the quarter that ended in Jun. 2026 was 193.55.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cathay Biotech's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cathay Biotech's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 1.37.

Cathay Biotech  (SHSE:688065) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cathay Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=1403.796/661.834*365 / 4
=193.55

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cathay Biotech's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=661.834 / 1403.796
=0.47

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cathay Biotech's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=1403.796 / 1025.651
=1.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cathay Biotech Change In Inventory Related Terms

Cathay Biotech Change In Inventory Historical Data

* Premium members only.

The historical data trend for Cathay Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cathay Biotech Change In Inventory Chart

Cathay Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -282.62 -418.06 78.30 198.51 -395.29

Cathay Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:688065
93GF Score
Cathay Biotech Inc SHSE:688065
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cathay Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of ¥0 Mil mean?
Cathay Biotech (SHSE:688065) has a Change In Inventory of ¥0 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cathay Biotech and its competitors.
Is Cathay Biotech's Change In Inventory too high?
Cathay Biotech's current Change In Inventory is ¥0 Mil. Overall, Cathay Biotech has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cathay Biotech's Change In Inventory compare to DOW?
Cathay Biotech's Change In Inventory of ¥0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Chemicals company?
A good Change In Inventory depends on the Chemicals industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cathay Biotech and its competitors. Cathay Biotech's current Change In Inventory is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cathay Biotech stock overvalued right now?
Based on GuruFocus' analysis, Cathay Biotech (SHSE:688065) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥49.84, compared to a current price of ¥39.86 — trading 20% below its estimated fair value. The current Change In Inventory is ¥0 Mil. Cathay Biotech's overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Cathay Biotech (SHSE:688065), the current Change In Inventory is ¥0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cathay Biotech (SHSE:688065) Overvalued in 2026?

Based on GuruFocus' analysis, Cathay Biotech stock appears to be undervalued. The current stock price of ¥39.86 is trading 20% below its estimated GF Value™ of ¥49.84. GuruFocus considers Cathay Biotech to be Modestly Undervalued.

Key valuation signals for SHSE:688065:

  • Change In Inventory: ¥0 Mil
  • GF Value™: ¥49.84 vs. price of ¥39.86 (20% below fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688065 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cathay Biotech Business Description

Address Oasis Ring Road, Building 11, Lane 396, Minhang District, Shanghai, CHN, 201114
Cathay Biotech Inc is engaged in research, development, production, and sales of new bio-based materials. The company owns the TERRYL brand, which focuses on bio-based polyamide fibers for textiles, and ECOPENT, which serves the engineering materials market.
93GF Score

Get the complete analysis for SHSE:688065

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥39.86
Price
¥49.84
GF Value